The criticism of The Lancet, NEJM and JAMA is not new, but the health secretary may use his position to influence research ...

Since President Donald J. Trump took office a second time on Jan. 20, leaders across the biotechnology and pharmaceutical ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international collaboration.

Broad changes within, partnerships without As ... this figure rises to around 10% of national emissions, with the pharma industry making up around 20% of that total. During a conference on ...

Top interviews with industry experts driving change in pharmaceutical production. Standout news pieces covering recent breakthroughs, challenges, and market shifts. Key pieces written by our ...

President Donald Trump’s plan to change the pricing model for some medications is facing fierce criticism from the pharmaceutical industry before he’s even signed an executive order he says will lower ...

The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered ...

The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to shift. With over thirty years experience in pharma Tapan Ray has a broad overview of ...

For pharma, an industry in which gross margins are among ... pharmaceuticals in a bid to impose levies on the sector. But changes to the tax code could prove even more crucial to long-term investment.

The pharmaceutical industry has the largest lobbying budget ... continues to flood Washington with ads urging Congress to make changes to Biden’s Medicare drug price negotiation law and to ...

The ABPI said that plan will fail without changes to the clawback scheme. Relations between the pharma industry and the government over the scheme and other policies have long been contentious.